Correlation Between Hepion Pharmaceuticals and Galectin Therapeutics

Can any of the company-specific risk be diversified away by investing in both Hepion Pharmaceuticals and Galectin Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Hepion Pharmaceuticals and Galectin Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Hepion Pharmaceuticals and Galectin Therapeutics, you can compare the effects of market volatilities on Hepion Pharmaceuticals and Galectin Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Hepion Pharmaceuticals with a short position of Galectin Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Hepion Pharmaceuticals and Galectin Therapeutics.

Diversification Opportunities for Hepion Pharmaceuticals and Galectin Therapeutics

0.44

Correlation Coefficient

Hepion Pharmaceuticals  Galectin Therapeutics

Very weak diversification

The 3 months correlation between Hepion and Galectin is 0.44. Overlapping area represents the amount of risk that can be diversified away by holding Hepion Pharmaceuticals and Galectin Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Galectin Therapeutics and Hepion Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Hepion Pharmaceuticals are associated (or correlated) with Galectin Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Galectin Therapeutics has no effect on the direction of Hepion Pharmaceuticals i.e., Hepion Pharmaceuticals and Galectin Therapeutics go up and down completely randomly.

Pair Corralation between Hepion Pharmaceuticals and Galectin Therapeutics

Given the investment horizon of 90 days Hepion Pharmaceuticals is expected to generate 0.47 times more return on investment than Galectin Therapeutics. However, Hepion Pharmaceuticals is 2.12 times less risky than Galectin Therapeutics. It trades about -0.28 of its potential returns per unit of risk. Galectin Therapeutics is currently generating about -0.32 per unit of risk. If you would invest  69.00  in Hepion Pharmaceuticals on September 21, 2024 and sell it today you would lose (20.85) from holding Hepion Pharmaceuticals or give up 30.22% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Hepion Pharmaceuticals  vs.  Galectin Therapeutics

Hepion Pharmaceuticals

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Hepion Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Despite uncertain performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Galectin Therapeutics

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Galectin Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of conflicting performance in the last few months, the Stock's essential indicators remain comparatively stable which may send shares a bit higher in January 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Pair Trading with Hepion Pharmaceuticals and Galectin Therapeutics

The main advantage of trading using opposite Hepion Pharmaceuticals and Galectin Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Hepion Pharmaceuticals position performs unexpectedly, Galectin Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Galectin Therapeutics will offset losses from the drop in Galectin Therapeutics' long position.

The idea behind Hepion Pharmaceuticals and Galectin Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.